Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34596937

Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Pediatr Blood Cancer
Publication date
2021 Dec
First author
Elgarten CW

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Elgarten CW
      type
      Author
    2. name
      Wood AC
      type
      Author
    3. name
      Li Y
      type
      Author
    4. name
      Alonzo TA
      type
      Author
    5. name
      Brodersen LE
      type
      Author
    6. name
      Gerbing RB
      type
      Author
    7. name
      Getz KD
      type
      Author
    8. name
      Huang YV
      type
      Author
    9. name
      Loken M
      type
      Author
    10. name
      Meshinchi S
      type
      Author
    11. name
      Pollard JA
      type
      Author
    12. name
      Sung L
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Elgarten CW
      type
      Author
    2. name
      Wood AC
      type
      Author
    3. name
      Li Y
      type
      Author
    4. name
      Alonzo TA
      type
      Author
    5. name
      Brodersen LE
      type
      Author
    6. name
      Gerbing RB
      type
      Author
    7. name
      Getz KD
      type
      Author
    8. name
      Huang YV
      type
      Author
    9. name
      Loken M
      type
      Author
    10. name
      Meshinchi S
      type
      Author
    11. name
      Pollard JA
      type
      Author
    12. name
      Sung L
      type
      Author
    bibliography ids
    1. nci-bib-d20e428d9bcc3f01266d348a
    book metadata
    content sha256
    b48d715ef229bf10284bdf28dee33259aa8c5ef501d2a77390e0709aeaa1202d
    document type
    citation
    dois
    1. 10.1002/pbc.29281
    electronic publication date
    display
    2021 Oct 1
    precision
    day
    year
    2021
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:34596937
    immutable id
    pubmed:34596937@b48d715ef229bf10284bdf28dee33259aa8c5ef501d2a77390e0709aeaa1202d
    journal
    abbreviation
    Pediatr Blood Cancer
    issn electronic
    1545-5017
    issn print
    1545-5009
    issue
    12
    name
    Pediatric blood & cancer
    nlm unique id
    101186624
    pages
    e29281
    volume
    68
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      34596937
      provenance
      batch id
      192b6392c165c6b06274
      provider
      NCBI PubMed ESummary
      record sha256
      eb9de5bc75a25ce67e18f374bb3f96d065565a7a593da3e9dc95d6e2c983310e
      response sha256
      7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
      retrieved at
      2026-09-09T23:48:02.713075+00:00
      publication date
      display
      2021 Dec
      precision
      month
      year
      2021
      publication types
      1. Journal Article
      2. Research Support, N.I.H., Extramural
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/34596937/
      title
      Outcomes of intensification of induction chemotherapy for children with high-risk acute myeloid leukemia: A report from the Children's Oncology Group.

      Preserved source evidence · Not medical advice